ENTITY

GT Biopharma (GTBP US)

2
Analysis
Health Care • United States
GT Biopharma, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions, and other unmet medical needs. GT Biopharma serves customers worldwide.
more
Exchange Announcement • 10 Oct 2026 05:27

S-1 | IPO Registration

Exchange Announcement • 15 Sep 2026 20:57

Current Report (Form 8-K | Period ending 2026-09-14)

Exchange Announcement • 03 Sep 2026 23:45

Current Report (Form 8-K | Period ending 2026-09-02)

Exchange Announcement • 14 Aug 2026 20:01

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 13 Jun 2026 04:30

Current Report (Form 8-K | Period ending 2026-06-08)

x